Subhasree Basu

The Wistar Institute — United States

Medicine · Health Sciences

4h-index79citations31works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(17), Radiopharmaceutical Chemistry and Applications(7), Mass Spectrometry Techniques and Applications(4), Redox biology and oxidative stress(4), Advanced Text Analysis Techniques(3)

Publications31 total

Expression of Prostate-Specific Membrane Antigen in Salivary Gland Tumors
Oncology and Therapy·2025Open Access
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor–resistant <i>NRAS</i> -mutant melanoma
Science Translational Medicine·2025· 2 citedOpen Access
FIGURE 5 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 3 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 4 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Data Legends from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Data from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Table 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Figure 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 5 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Data Legends from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Data from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Figure 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Figure 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Figure 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
FIGURE 2 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
Supplementary Table 1 from The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Brent Rupnow(24), Lucie Van Emmenis(23), Sheng‐Yu Ku(23), Kaitlyn Gayvert(23), Jonathan R. Branch(23), Nicholas J. Brady(23), Mike R. Russell(23), Joanna Cyrta(23), Aram Vosoughi(23), Verena Sailer(23), Hussein Alnajar(23), Étienne Dardenne(23), Elena Koumis(23), Loredana Puca(23), Brian D. Robinson(23), Michael D. Feldkamp(23), Annmarie Winkis(23), Nathan Majewski(23), Marco M. Gottardis(23), Olivier Elemento(23)